# La Renon Healthcare Pvt.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/la-renon-healthcare-pvt

- Industry: Pharmaceuticals
- Headquarters: Ahmedabad, India
- Website: www.larenon.com/
- Total disclosed funding: $16M
- Latest round: Series A (Jun 12, 2015)
- Investors on record: 1

## About

Based in Gujarat, India, and founded by Pankaj Singh (Chairman and MD) in 2007, La Renon Healthcare Pvt. Ltd. operates as a developer and manufacturer of pharmaceutical products. In September 2025, a consortium led by White Oak Capital Management, Siguler Guff, Creador and Avendus PE Investment Advisors acquired minority stake in La Renon Healthcare Pvt. Ltd for INR 10 million

The company offers pharmaceutical products and services for various critical illnesses and diseases such as Nephrology, Critical Care, CNS, Gastroenterology, Urology, Cardio-Metabolic, Respiratory, and Gynaecology. Some examples of La Renon's products include Silodosin 8 mg Tablets for Benign Prostatic Hyperplasia, Amisulpride Injection 5mg/2ml for post-operative nausea and vomiting therapy, Alfuzosin 10mg Prolonged Release Tablets for Urology, etc. La Renon also has an in-house research and development (R&D) center, developing formulations and processes, transferring technology to manufacturing facilities like Stanford Labs, a subsidiary. 

La Renon Healthcare Pvt. Ltd. generates revenue by manufacturing and selling branded chronic-therapy pharmaceutical formulations across nephrology, CNS, gastro, gynaecology and cardio-diabetology segments, supported by nationwide distribution. The company plans the September 2025 funding to grow and expand its business.

## Funding rounds

- Series A, Jun 12, 2015, $16M — Hong Shan

## Investors

- Hong Shan — Series A